Crescent Capital BDC (CCAP) Q2 2024 earnings summary
Event summary combining transcript, slides, and related documents.
Q2 2024 earnings summary
1 Feb, 2026Executive summary
Reported Q2 2024 net investment income of $0.59 per share and net income of $0.55 per share; net asset value per share rose to $20.30, the highest since June 2022.
Portfolio diversified across 183 companies in 20 industries, with 90% in senior secured first lien and unitranche first lien investments by fair value.
Portfolio remains defensively positioned with strong credit performance, stable nonaccrual levels, and high floating rate exposure.
Declared a Q3 2024 regular dividend of $0.42 per share and a Q2 2024 supplemental dividend of $0.09 per share.
Total assets reached $1.67 billion, with stockholders' equity at $752 million as of June 30, 2024.
Financial highlights
Q2 2024 total investment income was $49 million, up from $46.7 million in Q2 2023, but down from $50.4 million in the prior quarter.
Net investment income per share was $0.59, down from $0.63 in the prior quarter, but up from $0.56 year-over-year.
Net income per share was $0.55 for Q2 2024.
Regular and supplemental dividends declared in Q2 2024 totaled $0.53 per share.
Debt-to-equity ratio stood at 1.18x, with asset coverage at 184%.
Outlook and guidance
Confident in continued strong portfolio performance and ability to deliver attractive risk-adjusted returns for the remainder of 2024.
Board declared a regular Q3 2024 dividend of $0.42 per share and plans to continue quarterly supplemental dividends.
Management continues to focus on disciplined portfolio construction and conservative investment strategy.
Asset coverage ratio remains strong at 184%, supporting ongoing leverage and investment activity.
Portfolio remains defensively positioned, with strong liquidity: $36.1 million in cash and $293.8 million undrawn debt capacity.
Latest events from Crescent Capital BDC
- Q4 net investment income covered the dividend, with NAV at $19.10 and a defensively positioned portfolio.CCAP
Q4 202526 Feb 2026 - Q3 net investment income rose to $0.64 per share, with strong liquidity and low non-accruals.CCAP
Q3 202414 Jan 2026 - Q4 2024 featured lower NII, stable NAV, robust liquidity, and special dividends for 2025.CCAP
Q4 202424 Dec 2025 - Board urges ratification of Ernst & Young LLP as auditor, with 2024 fees totaling $841,150.CCAP
Proxy Filing2 Dec 2025 - Director elections and auditor ratification headline the 2025 annual meeting agenda.CCAP
Proxy Filing2 Dec 2025 - Stockholders will vote virtually on director elections and auditor ratification, with strong board oversight.CCAP
Proxy Filing2 Dec 2025 - Net investment income and NAV per share fell, but dividends and portfolio quality remain strong.CCAP
Q1 202526 Nov 2025 - Q2 2025 delivered strong income, stable NAV, and a $20M share repurchase program.CCAP
Q2 202523 Nov 2025 - Net investment income steady at $0.46 per share; NAV and net income per share declined.CCAP
Q3 202517 Nov 2025